Thermo Scientific Orbitrap Tribrid mass spectrometers employing the Tandem Mass Tags (TMT) enables researchers to better understand the proteome
Study confirms advantages of the in vitro diagnostic test kit MammaTyper® over immunohistochemistry
New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture
Cellca’s cell line and upstream process development services now integrated
Read the highlights from this SelectScience® webinar
Porvair’s range of 384-well plates are produced under strict conditions to ensure the highest quality
Unique trapped ion mobility spectrometry (TIMS) coupled to Bruker’s high-performance QTOF mass spectrometry enables high-resolution compound separation, significant duty cycle enhancements and studies of protein conformations, aggregation and structural isomers
New application study demonstrates the plasma protein analyzing abilities of Postnova Analytics’ AF4-ICP-MS system
Read highlights from this indispensable webinar
International competition rewards three top proteomics researchers for outstanding innovation and impact
New SureSeq™ FFPE DNA Repair Mix delivers excellent sequencing data for confident variant calling from minimal DNA input
Photometrics Prime 95B leverages backside illuminated sensor technology providing three times more sensitivity than previous scientific CMOS cameras
This year’s research prize awarded by Eppendorf goes to Belgium
Thermo Fisher Scientific host a series of informative breakfast seminars for ASMS attendees
The all-new rapifleX™ extends MALDI leadership in protein characterization, biologics development and QC, as well as in Mass Spectrometry Imaging (MSI)
Company now selling directly to customers in South Korea
Dr Tony Ludlam, Protein Core Manager, Cayman Chemical, tells SelectScience® about the technology improving protein production
New innovative ZipChip microfluidic inlet technology designed for fast MS analysis of biomolecules
Future joint collaborations are expected as work continues to unlock the full clinical and research potential of both technologies
Reference data set from Horizon affirms proven accuracy of GeneReader workflow
Cell Culture Solutions from Olympus
Studies demonstrate pioneering research possible using ChIP technology
34-gene panel for assessing risk of 15 inherited cancers among new Quest Vantage™ test services to be highlighted during the 2016 ASCO Annual Meeting
